Immunotherapy in Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|39|6|335-345

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.6, 2016-05, pp. : 335-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Analysis of the Safety of Herceptin^® Immunotherapy in Metastatic Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 58-66

Karger

Access to resources Recommend Favorite

Activated T-Cell and Bispecific Antibody Immunotherapy for High-Risk Breast Cancer

Acta Haematologica, Vol. 105, Iss. 3, 2001-07 ,pp. : 130-136

Karger

Access to resources Recommend Favorite

Cancer immunotherapy

By Baxevanis Constantin N. Perez Sonia A. Papamichail Michael

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 4, 2009-08 ,pp. : 167-189

Informa Healthcare

Access to resources Recommend Favorite

Polymeric nanoparticulates for cancer immunotherapy

By Li Wei Feng Si-Shen Guo Yajun

Nanomedicine, Vol. 8, Iss. 5, 2013-05 ,pp. : 679-682

Future Medicine

Access to resources Recommend Favorite

Immunotherapy of Lung Cancer: An Update

Oncology Research and Treatment, Vol. 29, Iss. 1-2, 2006-01 ,pp. : 33-38

Karger

Access to resources Recommend Favorite